Sam Yenne is the Chief Executive Officer at Metalytics. Sam has over 25 years of corporate leadership along with product discovery and development expertise in the life sciences and related industries. Most recently, Sam was CEO of a biofuels company where he secured in excess of $7 million in funding while advancing the company through product development. Dr. Yenne has held positions of Project Manager and VP of Development in four different biotechnology companies where he was responsible for developing products from inception to market launch. Prior to this Sam was a strategic business consultant, a project manager for an international chemical and life sciences company, and a scientist conducting complex biological experiments to determine the fate of xenobiotic compounds. Sam earned his MBA from Duke University, his Ph.D. from Virginia Tech, and his B.S. and M.S. degrees from the University of Idaho.
Jamey is an associate professor in both the Chemical & Biomolecular Engineering and Molecular Physiology & Biophysics Departments at Vanderbilt University in Nashville, TN. He received his PhD (2005) in Chemical Engineering at Purdue University and was a post-doctoral fellow at MIT. His current research applies metabolic engineering in combination with current biochemical and molecular biology approaches to investigate a variety of cell models of relevance to medicine and biotechnology. Jamey developed the proprietary flux analysis software, INCATM, and his innovative research has been recognized with various awards, including a NSF CAREER Award and a DOE Early Career Award.
Eric Cumming is Chief Strategy Officer, VP Business Development at Metalytics. He has over 25 years of executive, entrepreneurial, and business strategy experience in technology, health and biotechnology, building systems, energy, and venture funding. Eric’s roles have also included product conceptualization and development, technology architecture, as well as product management and investment fund raising. Eric earned his MBA from the University of Michigan and his B.Sc. from Oakland University.
As VP of Research and Development at Metalytics, Doug is responsible for leading our product development and product delivery efforts. Dr. Lee was previously the founder of a life science data analysis company that integrates data from genomic, transcriptomic, proteomic, metabolomic and lipidomic studies to reveal compelling narratives, accelerating cancer research, drug development and enhancing biologics manufacturing. He has 15 years of combined experience in scientific research, process development in biologics manufacturing and providing contract research services, including 9 years of metabolomics data interpretation. Doug Lee holds a PhD in biochemistry and medical genetics, and a BSc in microbiology, both degrees from the University of Manitoba (Canada). He completed his post-doctoral fellowship training in the Department of Nutrition at UNC-Chapel Hill.
Lara received her PhD (2015) in Chemical Engineering from Vanderbilt University, as well as a BS (2010) in Chemical Engineering and a BS (2010) in Polymer & Color Chemistry, both from North Carolina State University. As a Department of Energy Office of Science Graduate Fellow during her PhD training, her research was focused on applying metabolic engineering and metabolic flux analysis techniques to bacterial and plant systems for improved production and metabolic efficiency. Lara was the Entrepreneurial Lead for her team that was chosen to take part in the National Science Foundation’s Spring 2015 Innovation-Corps program, which led to the formation of Metalytics.